Dr Melanie Saville | Director Of Vaccine Development- Uk
CEPI | France

Dr Melanie Saville, Director Of Vaccine Development- Uk, CEPI

Melanie Saville joined the Coalition for Epidemic Preparedness Innovations (CEPI) in November 2017 initially as Head of Clinical development and now as Director Vaccine Development. Melanie is a physician specialized in virology with more than 18 years’ experience in the development and licensure of vaccines for the developed and developing world. Over the years, she has contributed to the development and licensure of several vaccines for seasonal and pandemic influenza, pediatric combinations, Rabies, Japanese Encephalitis and Dengue vaccine in Europe, US and the international area.
Joining Wyeth in 2000 in the UK, Melanie led the phase III clinical development of a live attenuated intranasal influenza vaccine. In addition, she contributed to several vaccine projects in early development involving adjuvants, immune modulators, viral vectors and conjugate technology.
In 2004 she joined Sanofi Pasteur in Lyon, France where she initially led the clinical influenza franchise having oversight of the clinical development of several differentiated seasonal influenza vaccine and pandemic vaccines. She then led the clinical development of a candidate dengue vaccine moving into phase III. Subsequently she became the Head of Clinical Development for a portfolio of vaccine projects managed out of the EU site. In 2013 she took on a broad role of Chief Medical and Clinical Officer Dengue having responsibility for the clinical development and licensure of the candidate Dengue vaccine.
In 2016 she joined Janssen Vaccines and prevention in the role of Head Late Development, Clinical and Medical Affairs overseeing several vaccines in development including for Ebola, HIV, RSV and E. coli.
Prior to joining industry, Melanie worked as a clinical virologist and conducted research at the Health protection Agency in London in the field of RSV and HSV.
Melanie obtained her medical degree from University College, London in 1993. She also obtained a Bachelor of Science in Molecular Biology from University College, London and a Masters in Medical Virology from Imperial College, London.


Oct 29th Day 1 @ 08:40

Paradigm shift in vaccine funding capacity and collaborations for disease X and persistent epidemics

  • How are we incentivizing vaccine development?
  • How will these vaccines reach the LMICs and developing countries?
  • CEPI’s strategy and investment to advance medical countermeasures to emerging diseases
  • The potential of translational medicine and access for all
  • How to secure public funding to advance research and vaccine development

Oct 30th Day 2 @ 09:05

Pandemic preparedness - How to proceed in the absence of an outbreak?

Examples from Ebola and Zika
last published: 16/Sep/19 14:05 GMT

back to speakers

Sign Up for Event Updates